GSK’s Jemperli In Search Of Lung Cancer Foothold And TIM-3 Combo Could Be Best Chance

Keytruda Head-To-Head Is Ambitious

 
• By Andrew McConaghie
  
new gsk logo and hq
GSK is rebuilding its presence in oncology, and hopes Jemperli can be the backbone of its immunotherapy franchise. • Source: GSK
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip